Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Quick Stats
Jan 30, 202653.5
AI Score
HOLD1.16
Volume Ratio
Feb 25, 2026
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
SRPT Stock Summary
Last updated Jan 30, 2026
SRPT is currently trading at $20.34, positioned below its 200-day moving average of $25.1, suggesting bearish momentum. The stock has a 52-week range of $10.415 to $120.05.
Technical Analysis: The 50-day moving average stands at $21.21, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 43.23, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.188, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates SRPT at 53.5/100 with a HOLD recommendation.
SRPT (Sarepta Therapeutics,, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 43.23 |
| CMF (20) | -0.188 |
| ROC (10) | -4.552 |
| ADX (14) | 11.581 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.092 |
| AROONOSC (14) | 28.571 |
| WILLAMS %R (14) | -94.76 |
| MFI (14) | 41.673 |
SRPT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
SRPT Price vs Max Options Open Interest
SRPT Max Change In Options Open Interest
SRPT Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SRPT Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SRPT Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SRPT Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Sarepta Therapeutics,, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
SRPT Moving Averages Analysis
SRPT (Sarepta Therapeutics,, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 21.43 |
| 20 | 21.81 |
| 30 | 21.71 |
| 50 | 21.21 |
| 100 | 20.73 |
| 200 | 25.1 |
SRPT Fundamental Analysis
| P/E (Forward) | 17.1821 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.2 billion |
| Earnings/Share ($) | -2.83 |
| Net Proft Margin (%) | -0.1125 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.9948 |
| EPS Estimate Next Year ($) | 3.1223 |
| WallStreet Target Price ($) | 21.4348 |
| Most Recent Quarter |
Sarepta Therapeutics ($SRPT) is being touted as a strong investment opportunity by some investors, with potential for significant gains in the near future. Despite recent fluctuations, confidence remains high in the company's prospects. Short sellers are facing challenges, and there is anticipation for positive news to be released soon. Investors are advised to hold onto their shares for potential profits in the coming months.
Updated 2025-10-08 16:00:02